My Cart [ 0 ]
New Products
New Services
News
Promotions
Home > Search Results
    474 products and services containing "cas no"
    Please click cas no to try advanced search.
  • C073P: Liraglutide Biosimilar

    Source: The recombinant peptide liraglutide biosimilar was produced in the liraglutide stable cell line. 
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by liraglutide.
    Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

  • C074P: Semaglutide Biosimilar

    Source: The recombinant peptide semaglutide biosimilar was produced in the semaglutide stable cell line. 
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
    Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

    C074PS: Semaglutide Synthetic Peptide

    Source: The semaglutide peptide was synthesized.
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

  • C128P: Tirzepatide Biosimilar

    Source: The recombinant peptide tirzepatide biosimilar was produced in the tirzepatide stable cell line. 
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tirzepatide.
    Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

    C128PS: Tirzepatide Synthetic Peptide

    Source: The tirzepatide peptide was synthesized.
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tirzepatide.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

  • C129P: Retatrutide Biosimilar

    Source: The recombinant peptide retatrutide biosimilar was produced in the retatrutide stable cell line. 
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by retatrutide.
    Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

    C129PS: Retatrutide Synthetic Peptide

    Source: The retatrutide peptide was synthesized.
    Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by retatrutide.
    Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

  • BP006254: Recombinant Human Insulin (Cell Culture Grade)

    Recombinant human insulin is frequently employed as a culture supplement in cell cultivation systems. Historically recognized as a critical factor for regulating growth and differentiation in most cell types in vitro, its working concentration typically ranges from 1–10 µg/mL (dynamically optimized for specific cell types). In serum-free culture protocols, insulin is often immobilized onto polystyrene culture dish surfaces.

    Purity: 95%-105%.
    Biological Activity: Approx. 20 units/mg.
     

  • APIM050515: DMT-2'-O-MOE-T-CE-Phosphoramidite

    CAS No.: 163878-63-5.
    Molecular Formula:  C43H55N4O10P.
    Molecular Weight:   818.90.
    Purity: (31P NMR) ≥99.0%; (RP-HPLC) ≥99.0%. 
    Impurity profile: (HPLC) any single critical impurity ≤ 0.15%; total critical impurities ≤ 0.3%; total impurities ≤ 1.0%.
    Assay: (HPLC) 98.0%~102.0%.

  • APIM050514: 5-Me-DMT-2'-O-MOE-C(Bz)-CE-Phosphoramidite

    CAS No.: 163759-94-2.
    Molecular Formula: C50H60N5O10P.
    Molecular Weight:   922.04.
    Purity: (31P NMR) ≥99.0%; (RP-HPLC) ≥99.0%. 
    Impurity profile: (HPLC) any single critical impurity ≤ 0.15%; total critical impurities ≤ 0.3%; total impurities ≤ 1.0%.
    Assay: (HPLC) 98.0%~102.0%.

  • APIM050513: DMT-2'-O-MOE-G(iBu)-CE-Phosphoramidite

    CAS No.:251647-55-9.
    Molecular Formula: C47H60N7O10P.
    Molecular Weight:   914.01.
    Purity: (31P NMR) ≥99.0%; (RP-HPLC) ≥99.0%. 
    Impurity profile: (HPLC) any single critical impurity ≤ 0.15%; total critical impurities ≤ 0.3%; total impurities ≤ 1.0%.
    Assay: (HPLC) 98.0%~102.0%.

  • APIM050512: DMT-2'-O-MOE-A(Bz)-CE-Phosphoramidite

    CAS No.:251647-53-7.
    Molecular Formula: C50H58N7O9P.
    Molecular Weight:  932.03.
    Purity: (31P NMR) ≥99.0%; (RP-HPLC) ≥99.0%. 
    Impurity profile: (HPLC) any single critical impurity ≤ 0.15%; total critical impurities ≤ 0.3%; total impurities ≤ 1.0%.
    Assay: (HPLC) 98.0%~102.0%.

  • APIM050521: DMT-dT-CE-Phosphoramidite

    CAS No.: 98796-51-1.
    Molecular Formula: C40H49N4O8P.
    Molecular Weight: 744.81.
    Purity: (31P NMR) ≥99.0%; (RP-HPLC) ≥99.0%. 
    Impurity profile: (HPLC) any single critical impurity ≤ 0.15%; total critical impurities ≤ 0.3%; total impurities ≤ 1.0%.
    Assay: (HPLC) 98.0%~102.0%.

See our Privacy Policy